#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Round cell liposarcoma Langerhans cell sarcoma Acute on chronic liver failure Osteomyelitis Encephalitis autoimmune Acquired haemophilia Diffuse large B-cell lymphoma Fallopian tube cancer Immune-mediated myositis Oesophageal adenocarcinoma Colorectal adenocarcinoma Ovarian cancer Fusarium infection Partial lipodystrophy Systemic mastocytosis More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Treatment Thrombotic thrombocytopenic purpura – Treatment Medulloblastoma – Basic Information Urea cycle disorder – Diagnostics Glomerulonephritis rapidly progressive – Basic Information Erdheim-Chester disease Indolent systemic mastocytosis – Basic Information Lennox-Gastaut syndrome – Trials in Disease Mucopolysaccharidosis I – Diagnostics Haemophagocytic lymphohistiocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gen1047 Liraglutide Befiradol (18F) Baloxavir Marboxil Bexotegrast Cart 19/22 T Cells Lixudebart Lutikizumab Clobetasol Gt005 Interleukin-2 Hyoscine Butylbromide Colchicine Catequentinib Dihydrochloride Volixibat Amantadine Hydrochloride Ofloxacin Ferric Derisomaltose Risperidone Ribonucleic Acid K30 More therapies…

    Learn about Your Condition

    Bronchitis Cardiac sarcoidosis Fabry's disease Skin disorder Epstein-Barr virus infection Habitual abortion Chronic coronary syndrome Renal impairment Renal cancer metastatic Insulin resistance Endometrial cancer Chondrosarcoma Hyperparathyroidism primary Systemic mastocytosis Muscle hypertrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Tenon

Hopital Tenon

4 Rue De La Chine, Paris, 75970, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Switching from Anti-C5 Antibody Therapy to Iptacopan for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)

    Recruiting

    3 1 1
    Investigated Drugs:
    • Iptacopan
    France Germany Italy Spain

  • Study Comparing Ciprofloxacin, Colistimethate Sodium, and Ceftazidime for Treating Early Airway Infection in Adults with Bronchiectasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Colistimethate Sodium
    • Ciprofloxacin
    • Ceftazidime Pentahydrate
    France

  • Study on Anakinra and Colchicine for Painful Attacks in Familial Mediterranean Fever Patients Resistant to Colchicine Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anakinra
    • Colchicine
    France

  • Study on Durvalumab, Etoposide, and Platinum Drug Combination for First-Line Treatment of Advanced Large-Cell Neuroendocrine Lung Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour of the lung
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    France

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Erythromycin Lactobionate
    • Oseltamivir
    • Roxithromycin
    Belgium Croatia Czechia Estonia France Germany +7

  • Study on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Darunavir
    • Ritonavir
    • Dolutegravir Sodium
    France

  • Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    • Cabozantinib
    • Ipilimumab
    Austria Belgium Czechia Denmark Finland France +5

  • Comparison of Cyclophosphamide and Doxorubicin for Treatment of Advanced or Metastatic Soft Tissue Sarcoma in Patients Age 65 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Dexrazoxane Hydrochloride
    • Cyclophosphamide
    • Doxorubicin
    France

  • Study on Stiripentol for Patients Aged 6 and Older with Primary Hyperoxaluria Types 1, 2, or 3

    Recruiting

    3 1 1
    Investigated Diseases:
    • Primary hyperoxaluria
    Investigated Drugs:
    • Stiripentol
    Belgium France Italy

  • Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Capecitabine
    • Codeine Phosphate
    Austria Belgium Czechia Denmark Finland France +9
Previous Page
1 2 3 4 5 6 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!